A prediction model for advanced colorectal neoplasia in an asymptomatic screening population

被引:25
|
作者
Hong, Sung Noh [1 ]
Son, Hee Jung [1 ,2 ]
Choi, Sun Kyu [3 ]
Chang, Dong Kyung [1 ]
Kim, Young-Ho [1 ]
Jung, Sin-Ho [3 ,4 ]
Rhee, Poong-Lyul [1 ]
机构
[1] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[2] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea
[3] Samsung Med Ctr, Samsung Canc Res Inst, Biostat & Bioinformat Ctr, Seoul, South Korea
[4] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA
来源
PLOS ONE | 2017年 / 12卷 / 08期
关键词
MISSING DATA; RISK; CANCER; COLONOSCOPY; VALIDATION; GUIDELINES; SCORE; INDEX; TOOL; MEN;
D O I
10.1371/journal.pone.0181040
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background An electronic medical record (EMR) database of a large unselected population who received screening colonoscopies may minimize sampling error and represent real-world estimates of risk for screening target lesions of advanced colorectal neoplasia (CRN). Our aim was to develop and validate a prediction model for assessing the probability of advanced CRN using a clinical data warehouse. Methods A total of 49,450 screenees underwent their first colonoscopy as part of a health check-up from 2002 to 2012 at Samsung Medical Center, and the dataset was constructed by means of natural language processing from the computerized EMR system. The screenees were randomized into training and validation sets. The prediction model was developed using logistic regression. The model performance was validated and compared with existing models using area under receiver operating curve (AUC) analysis. Results In the training set, age, gender, smoking duration, drinking frequency, and aspirin use were identified as independent predictors for advanced CRN (adjusted P <.01). The developed model had good discrimination (AUC = 0.726) and was internally validated (AUC = 0.713). The high-risk group had a 3.7-fold increased risk of advanced CRN compared to the low-risk group (1.1% vs. 4.0%, P <.001). The discrimination performance of the present model for high-risk patients with advanced CRN was better than that of the Asia-Pacific Colorectal Screening score (AUC = 0.678, P <.001) and Schroy's CAN index (AUC = 0.672, P <.001). Conclusion The present 5-item risk model can be calculated readily using a simple questionnaire and can identify the low- and high-risk groups of advanced CRN at the first screening colonoscopy. This model may increase colorectal cancer risk awareness and assist healthcare providers in encouraging the high-risk group to undergo a colonoscopy.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps
    Martinez-Roca, Alejandro
    Cubiella, Joaquin
    Garcia-Heredia, Anabel
    Guill-Berbegal, David
    Baile-Maxia, Sandra
    Mangas-Sanjuan, Carolina
    Sala-Miquel, Noelia
    Madero-Velazquez, Lucia
    Alenda, Cristina
    Zapater, Pedro
    Gonzalez-Nunez, Clara
    Iglesias-Gomez, Agueda
    Codesido-Prado, Laura
    Diez-Martin, Astrid
    Kaminski, Michal F.
    Erichsen, Rune
    Adami, Hans-Olov
    Ferlitsch, Monika
    Pellise, Maria
    Holme, Oyvind
    Dekker, Evelien
    Bretthauer, Michael
    Jover, Rodrigo
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
  • [42] Screening for colorectal neoplasia
    Kronborg, O
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (02): : 127 - 129
  • [43] Smoking and the Association of Advanced Colorectal Neoplasia in an Asymptomatic Average Risk Population: Analysis of Exposure and Anatomical Location in Men and Women
    Anderson, Joseph C.
    Moezardalan, Koorosh
    Messina, Catherine R.
    Latreille, Michael
    Shaw, Robert D.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) : 3616 - 3623
  • [44] SCREENING FOR COLORECTAL NEOPLASIA
    PYE, G
    HARDCASTLE, JD
    PRACTITIONER, 1987, 231 (1424) : 183 - &
  • [45] Screening for Colorectal Neoplasia
    Imperiale, Thomas F.
    Ransohoff, David F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1598 - 1599
  • [46] Screening for Colorectal Neoplasia
    Inadomi, John M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 149 - 156
  • [47] EFFECTIVENESS OF THE IMMUNOCHEMICAL FECAL TEST (FIT) FOR DETECTION OF ADVANCED ADENOMAS IN COLORECTAL CARCINOMA SCREENING IN AN ASYMPTOMATIC POPULATION
    Miutescu, B.
    Sporea, I.
    Popescu, Alina
    Bota, Simona
    Iovanescu, Dana
    Burlea, Amelia
    Mos, Liana
    Palaghia, Madalina
    Vasilescu, A.
    Miutescu, E.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (02): : 302 - 307
  • [48] Colonoscopic screening of an average-risk population for colorectal neoplasia
    Boursi, B.
    Halak, A.
    Umansky, M.
    Galzan, L.
    Guzner-Gur, H.
    Arber, N.
    ENDOSCOPY, 2009, 41 (06) : 516 - 521
  • [49] Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
    Kong, Yunxin
    Zhuo, Lin
    Dong, Dong
    Zhuo, Lang
    Lou, Peian
    Cai, Ting
    Chen, Siting
    Pan, Jianqiang
    Gao, Yihuan
    Lu, Hang
    Ma, Yue
    Dong, Zongmei
    Luo, Xiaohu
    Zhao, Hongying
    BMC CANCER, 2022, 22 (01)
  • [50] Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
    Yunxin Kong
    Lin Zhuo
    Dong Dong
    Lang Zhuo
    Peian Lou
    Ting Cai
    Siting Chen
    Jianqiang Pan
    Yihuan Gao
    Hang Lu
    Yue Ma
    Zongmei Dong
    Xiaohu Luo
    Hongying Zhao
    BMC Cancer, 22